Showing results (101-110 of 436) with videos related to
Sort By:
Pageof 44
Nature Reviews. Immunology|November 7, 2024
Adipokines: masterminds of metabolic inflammationHerbert Tilg, Gianluca Ianiro, Antonio Gasbarrini, et al.Nature Metabolism|December 21, 2021
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunityHerbert Tilg, Timon E Adolph, Michael Dudek, et al.International Journal of Molecular Sciences|August 1, 2017
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple InteractionsTimon E Adolph, Christoph Grander, Felix Grabherr, et al.Mutation Research|July 9, 2009
Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone diseaseAlexander R Moschen, Sabine Geiger, Romana Gerner, et al.Gut|June 14, 2022
COVID-19 and liver diseaseJean-François Dufour, Thomas Marjot, Chiara Becchetti, et al.Current Pharmaceutical Design|March 29, 2018
Paneth Cells and their Antimicrobials in Intestinal ImmunityTimon E Adolph, Lisa Mayr, Felix Grabherr, et al.Nature Reviews. Immunology|August 8, 2019
The intestinal microbiota fuelling metabolic inflammationHerbert Tilg, Niv Zmora, Timon E Adolph, et al.Gut|November 26, 2024
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonistsGiovanni Targher, Alessandro Mantovani, Christopher D Byrne, et al.Gut|May 22, 2024
Heavy arch: from inflammatory bowel diseases to metabolic disordersTimon E Adolph, Moritz Meyer, Almina Jukic, et al.Nature Reviews. Gastroenterology & Hepatology|May 2, 2018
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver diseaseQuentin M Anstee, Alessandro Mantovani, Herbert Tilg, et al.Pageof 44